In March 2024, my wife had two Fibroscans, 14.2 and 14.7 with CAP in high 300's. She had a biopsy in July confirming severe steatosis and F3 fibrosis verging on F4. University of Utah liver clinic recommended a new drug called Rezdiffra. It's pricy like any new drug. But, there are foundations that will help with the cost. She was either the first one to get it in our area or one of the first. We just had another Fibroscan this morning. CAP was 301 and kPa was 9.2. This is very good news for us. We realize it is early and things can change but for right now we will enjoy the great news and continue hopeful and moving forward down the same path.
